1. B�nder, A.: Zum Wirkungsmechanismus blutzuckersenkender Sulfonylharnstoffe D 860 und BZ 55. Dtsch. med. Wschr.84, 996?1002 (1959).
2. Beyer, J., Sch�f�ing, K.: Clinical experiences with glibenclamide in 300 subjects. Symposium on Glibenclamide, 12. June 1970, The Royal College of Physicians, London NW 1. Postgrad, med. J., Suppl. to Vol.46, 78?83 (1970).
3. Bigler, F., Rentsch, G., Rieder, J.: Metabolism and pharmacokinetics of recent antidiabetics. Intern. Symposium on Recent Hypoglycemic Sulfonylureas, Basle, October 2.?3. 1970. Bern: Huber 1971 (in press).
4. Christ, O.E., Heptner, W., Rupp, W.: Investigations on Absorption, Excretion and Metabolism in man after Administration of14C-labelled HB 419. Horm. Metab. Res., Suppl. to Vol.1, 51?54 (1969).
5. Dole, P.V., Meinertz, H.: Microdetermination of long chain fatty acids in plasma and tissues. J. biol. Chem.235, 2595?2599 (1960).